Vulval squamous cell carcinoma (VSCC) can arise through two distinct pathways [human
papillomavirus (HPV)‐associated and HPV‐independent], and these VSCC variants are …

In der WHO-Klassifikation 2020 steht die Unterscheidung von HPV-assoziierten und HPV-
unabhängigen Plattenepithelkarzinomen des unteren weiblichen Genitales im Vordergrund …

The purpose of this guideline is to collate evidence and propose evidence-based guidelines
for the diagnosis and management of adult patients with vulva carcinoma treated in the UK …

The recent literature has shown that vulvar squamous cell carcinoma (VSCC) can be
stratified into two prognostically relevant groups based on human papillomavirus (HPV) …

Evidence was searched in the Cochrane Central Register of Controlled Trials (CENTRAL,
The Cochrane Library April 2022, Issue 4), MEDLINE and EMBASE up to April 2022, with …

Introduction Human papillomavirus (HPV), p16, and p53 have been investigated as
prognostic markers in various HPV‐related cancers. Within the field of vaginal cancer …

Papillomaviruses dysregulate the G1/S cell cycle transition in order to promote DNA
synthesis in S phase, which is a requirement for viral replication. The human …

Background There are 2 known pathways for tumorigenesis of vulvar squamous cell
carcinoma—a human papillomavirus–dependent pathway characterized by p16 …

Background Additional prognostic factors and personalized therapeutic alternatives for
vulvar squamous cell carcinoma (VSCC), especially for advanced stages with poor …

The primary aim of this study was to assess the association between human papilloma virus
(HPV) and p53 expression and local recurrence (LR), disease specific survival (DSS), and …